Numerion Labs
PrivateLast Round
Early Stage
VC
Mar 19, 2026
Est. Valuation
$1.71M
Total Funding Raised
$221.42M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Numerion Labs is a biotechnology company that develops an artificial intelligence-driven platform for small molecule drug discovery.
Sector
AI, Data & Cloud Infrastructure
Verticals
ML Platforms, Business Intelligence, Data Integration, Workflow Automation
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Numerion Labs Comparables
Compare Numerion Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Iambic Therapeutics | 79% | |
| Insilico Medicine | 78% | |
| Terray Therapeutics | 77% |
Numerion Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | Mar 19, 2026 | ||||
| Series C | Mar 1, 2024 | ||||
| Grant | Oct 6, 2020 | ||||
| Series B | Aug 11, 2020 | ||||
| Series A | Mar 7, 2018 | ||||
Seed | Jun 3, 2015 |
Numerion Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sanabil Investments | Series B |
| Threshold Ventures | Seed |
| Dolby Family Ventures | Series A, Series B |
| B Capital Group | Series C, Series A, Series B |
| Khosla Ventures | Series A, Seed, Series C |
| BV Investment Partners | Series B |
| Baidu Ventures | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors increased 47% MoM.
- Mar 19, 2026
$20M raised in early stage VC round.
Numerion Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Numerion Labs's valuation, stock price, and market status.
Is Atomwise a public or private company?
Atomwise is a private company.
What is the current stock price of Atomwise?
Atomwise is a private company with no public stock price. No recent secondary market data is available.
How much is Atomwise worth (valuation)?
Atomwise's valuation is estimated at $1.7M based on funding round data.
Can I buy Atomwise stock?
Atomwise shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Atomwise's last funding round?
Atomwise's most recent funding round was Grant on March 1, 2015.
Who are the main investors in Atomwise?
Key investors in Atomwise include Sanabil Investments, B Capital Group, Y Combinator, Leaps by Bayer, DCVC (Data Collective).
Will Atomwise IPO soon?
No public IPO plans have been announced for Atomwise.
How can I track Atomwise secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Atomwise's secondary market activity and sign up for updates.